Julianne Gee

8.5k total citations · 6 hit papers
74 papers, 4.6k citations indexed

About

Julianne Gee is a scholar working on Health, Epidemiology and Infectious Diseases. According to data from OpenAlex, Julianne Gee has authored 74 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Health, 34 papers in Epidemiology and 33 papers in Infectious Diseases. Recurrent topics in Julianne Gee's work include Vaccine Coverage and Hesitancy (39 papers), SARS-CoV-2 and COVID-19 Research (32 papers) and Cervical Cancer and HPV Research (17 papers). Julianne Gee is often cited by papers focused on Vaccine Coverage and Hesitancy (39 papers), SARS-CoV-2 and COVID-19 Research (32 papers) and Cervical Cancer and HPV Research (17 papers). Julianne Gee collaborates with scholars based in United States, Uganda and Kenya. Julianne Gee's co-authors include Tanya R. Myers, Lauri E. Markowitz, Tom T. Shimabukuro, John R. Su, Paige Marquez, Eric Weintraub, David K. Shay, Shannon Stokley, Allison L. Naleway and James Baggs and has published in prestigious journals such as JAMA, PEDIATRICS and Clinical Infectious Diseases.

In The Last Decade

Julianne Gee

73 papers receiving 4.4k citations

Hit Papers

Effects of the COVID-19 Pandemic on Routine... 2014 2026 2018 2022 2020 2014 2021 2021 2021 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
    2020 521 citations Matthew F. Daley, Julianne Gee et al. MMWR Morbidity and Mortality Weekly Report profile →
  2. Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.
    2014 447 citations Shannon Stokley, Jenny Jeyarajah et al. PubMed profile →
  3. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
    2021 371 citations John R. Su, Julianne Gee et al. MMWR Morbidity and Mortality Weekly Report profile →
  4. First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021
    2021 275 citations Julianne Gee, Paige Marquez et al. MMWR Morbidity and Mortality Weekly Report profile →
  5. Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines
    2021 229 citations Johanna Chapin-Bardales, Julianne Gee et al. profile →
  6. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe
    2022 116 citations Julianne Gee, Paige Marquez et al. profile →

Peers

Julianne Gee
Matthew F. Daley United States
Tom T. Shimabukuro United States
Allison L. Naleway United States
H. Keipp Talbot United States
Elyse O. Kharbanda United States
Flor M. Muñoz United States
James G. Donahue United States
Sara E. Oliver United States
Julia Stowe United Kingdom
Claudia Vellozzi United States
Matthew F. Daley United States
Julianne Gee
Citations per year, relative to Julianne Gee Julianne Gee (= 1×) peers Matthew F. Daley

Countries citing papers authored by Julianne Gee

Since Specialization
Citations

This map shows the geographic impact of Julianne Gee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julianne Gee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julianne Gee more than expected).

Fields of papers citing papers by Julianne Gee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julianne Gee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julianne Gee. The network helps show where Julianne Gee may publish in the future.

Co-authorship network of co-authors of Julianne Gee

This figure shows the co-authorship network connecting the top 25 collaborators of Julianne Gee. A scholar is included among the top collaborators of Julianne Gee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julianne Gee. Julianne Gee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meaney‐Delman, Dana, Kara N.D. Polen, Tara C. Jatlaoui, et al.. (2024). Planning for the future of maternal immunization: Building on lessons learned from the COVID-19 pandemic. Vaccine. 42. 125644–125644. 3 indexed citations
2.
3.
Woo, Emily Jane, Julianne Gee, Paige Marquez, et al.. (2023). Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022. Vaccine. 41(30). 4422–4430. 8 indexed citations
4.
Hause, Anne M., Paige Marquez, Bicheng Zhang, et al.. (2023). Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023. MMWR Morbidity and Mortality Weekly Report. 72(2). 39–43. 23 indexed citations
5.
Abara, Winston E., Julianne Gee, Paige Marquez, et al.. (2023). Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States. JAMA Network Open. 6(2). e2253845–e2253845. 41 indexed citations
6.
Tompkins, Lindsay K., James Baggs, Tanya R. Myers, et al.. (2022). Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults. Vaccine. 40(52). 7653–7659. 2 indexed citations
7.
Irving, Stephanie A., Holly C. Groom, Matthew F. Daley, et al.. (2022). A decade of data: Adolescent vaccination in the vaccine safety datalink, 2007 through 2016. Vaccine. 40(9). 1246–1252. 1 indexed citations
8.
Malden, Deborah E., Julianne Gee, Sungching Glenn, et al.. (2022). Reactions following Pfizer-BioNTech COVID-19 mRNA vaccination and related healthcare encounters among 7,077 children aged 5-11 years within an integrated healthcare system. Vaccine. 41(2). 315–322. 4 indexed citations
9.
Salmon, Daniel A., P H Lambert, Hanna Nohynek, et al.. (2021). Novel vaccine safety issues and areas that would benefit from further research. BMJ Global Health. 6(Suppl 2). e003814–e003814. 8 indexed citations
10.
Abara, Winston E., Julianne Gee, Mark Delorey, et al.. (2021). Expected Rates of Select Adverse Events After Immunization for Coronavirus Disease 2019 Vaccine Safety Monitoring. The Journal of Infectious Diseases. 225(9). 1569–1574. 7 indexed citations
11.
Chapin-Bardales, Johanna, Tanya R. Myers, Julianne Gee, et al.. (2021). Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system. Vaccine. 39(48). 7066–7073. 10 indexed citations
12.
Klein, Nicola P., Kristin Goddard, Edwin Lewis, et al.. (2019). Long term risk of developing type 1 diabetes after HPV vaccination in males and females. Vaccine. 37(14). 1938–1944. 11 indexed citations
13.
Gee, Julianne, Lakshmi Sukumaran, & Eric Weintraub. (2017). Risk of Guillain-Barré Syndrome following quadrivalent human papillomavirus vaccine in the Vaccine Safety Datalink. Vaccine. 35(43). 5756–5758. 18 indexed citations
14.
Baxter, Roger, Edwin Lewis, Bruce Fireman, et al.. (2016). Case-centered Analysis of Optic Neuritis After Vaccines: Table 1.. Clinical Infectious Diseases. 63(1). 79–81. 24 indexed citations
15.
Stokley, Shannon, Jenny Jeyarajah, David Yankey, et al.. (2014). Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.. PubMed. 63(29). 620–4. 447 indexed citations breakdown →
16.
McCarthy, Natalie, Stephanie A. Irving, James G. Donahue, et al.. (2013). Vaccination coverage levels among children enrolled in the Vaccine Safety Datalink. Vaccine. 31(49). 5822–5826. 17 indexed citations
17.
McCarthy, Natalie, Eric Weintraub, Claudia Vellozzi, et al.. (2013). Mortality Rates and Cause-of-Death Patterns in a Vaccinated Population. American Journal of Preventive Medicine. 45(1). 91–97. 21 indexed citations
18.
Naleway, Allison L., et al.. (2012). Reported Adverse Events in Young Women Following Quadrivalent Human Papillomavirus Vaccination. Journal of Women s Health. 21(4). 425–432. 22 indexed citations
19.
Gee, Julianne, Allison L. Naleway, Irene M. Shui, et al.. (2011). Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink. Vaccine. 29(46). 8279–8284. 170 indexed citations
20.
Xu, Fujie, Julianne Gee, Allison L. Naleway, et al.. (2008). Incidence of Neonatal Herpes Simplex Virus Infections in Two Managed Care Organizations: Implications for Surveillance. Sexually Transmitted Diseases. 35(6). 592–598. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew F. Daley Breakdown of academic impact, for papers by Tom T. Shimabukuro Breakdown of academic impact, for papers by Allison L. Naleway Breakdown of academic impact, for papers by H. Keipp Talbot Breakdown of academic impact, for papers by Elyse O. Kharbanda Breakdown of academic impact, for papers by Flor M. Muñoz Breakdown of academic impact, for papers by James G. Donahue Breakdown of academic impact, for papers by Sara E. Oliver Breakdown of academic impact, for papers by Julia Stowe Breakdown of academic impact, for papers by Claudia Vellozzi
Rankless by CCL
2026